Waltham, MA, United States of America

Allison Laura Choy

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2012-2013.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Allison Laura Choy

Introduction

Allison Laura Choy is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential medicinal applications. With a total of 2 patents to her name, her work is recognized for its impact on treating bacterial infections.

Latest Patents

Choy's latest patents include innovative compounds known as heterocyclic urea derivatives. These compounds, represented by formula (IA), and their pharmaceutically acceptable salts are described in detail. The patents outline processes for their preparation, pharmaceutical compositions containing them, and their use as medicaments in the treatment of bacterial infections. Another patent focuses on similar heterocyclic urea derivatives, emphasizing their potential in medical applications.

Career Highlights

Allison Laura Choy is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Choy has collaborated with esteemed colleagues such as Brian A. Sherer and Pamela Hill. These collaborations have further enhanced her research and development efforts, leading to innovative solutions in the field.

Conclusion

Allison Laura Choy's contributions to pharmaceutical innovations through her patents and collaborations highlight her role as a significant inventor in the industry. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…